Sentence examples for slow clinical response from inspiring English sources

Subtherapeutic levels of ATT have been associated with a slow clinical response, treatment failure and drug resistance [ 59].

In addition, slower clinical response and increased relapse rate have been associated with infections caused by MRSA with a high vancomycin MIC [ 10].

Possible reasons for this apparent reluctance to step-down to oral therapy at an early timepoint in this study may include the high percentage of non- albicans infections, the high proportion of critically ill post-abdominal surgery patients (who may have remained nil-by-mouth for a short period post-operation) and slower clinical response due to an immunocompromised state.

As an example, institutional antimicrobial resistance rates and the differential costs of antibiotics may matter far less to an ID physician than an ASP, resulting in a more conservative approach to de-escalating or stopping antibiotics in patients that have more complications or a slower clinical response, regardless of culture results.

Because these NalR CipDS Salmonella Typhi strains have been associated with slower clinical responses to fluoroquinolones and treatment failures, clinical laboratories should attempt to identify these isolates (3, 6, 7 ).

Clindamycin is safe and effective for the treatment of Plasmodium falciparum malaria, but its use as monotherapy is limited by unacceptably slow initial clinical response rates.

This indicates that prolonged courses of AS were still effective in curing the malaria infection despite slow clinical and parasitological responses.

These findings are consistent with the kinetics of the gradual clinical response and the slow but sure decrease in levels of circulating antibodies observed after rituximab treatment.

Clinical response to antimicrobials is slow and recurrent disease is common [ 5].

The efficacy of vancomycin against methicillin resistant S.aureus (MRSA) has been reported to be inferior to that of beta-lactams against methicillin susceptible S.aureus (MSSA) due to its slower in vitro bactericidal activity with a lower clinical response [ 4- 6].

This is in line with the observation that TNF blockers can even slow bone erosion in the absence of a major clinical response [ 43].